Home › Cancro (tutti i tipi) › Minnesota › Rochester
Studi clinici su Cancro (tutti i tipi) a Rochester, MN
30 studi su Cancro (tutti i tipi) cercano partecipanti presso sedi a Rochester e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
In reclutamentoFase 3
- Investigative Site, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
In reclutamentoStudio osservazionale
- Mayo Clinic Rochester, Rochester
A Study of JNJ-1761981 in Participants With Solid Tumors
In reclutamentoFase 1
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
In reclutamentoFase 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
In reclutamentoFase 3
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
In reclutamentoFase 2/3
- Mayo Clinic, Rochester
Statins to Prevent Cancer Associated Blood Clots
In reclutamentoFase 4
- Mayo Clinic, Rochester
Biomarkers of Resiliency In Childhood Cancer Surgery
In reclutamentoStudio osservazionale
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
In reclutamentoFase 1/2
- Mayo Clinic Rochester, Rochester
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
In reclutamentoStudio osservazionale
- Mayo Clinic Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
In reclutamentoFase 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Project: Every Child for Younger Patients With Cancer
In reclutamentoStudio osservazionale
- Mayo Clinic in Rochester, Rochester
Abatacept in Immune Checkpoint Inhibitor Myocarditis
In reclutamentoFase 3
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
In reclutamentoFase 3
- Mayo Clinic in Rochester, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
In reclutamentoFase 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
In reclutamentoFase 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
In reclutamentoFase 1
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Mayo Clinic Rochester, Rochester
Patient Derived Preclinical Models
In reclutamentoStudio osservazionale
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
In reclutamento
- Mayo Clinic, Rochester
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Mayo Clinic Rochester, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
In reclutamentoFase 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
In reclutamentoStudio osservazionale
- Mayo Clinic in Rochester, Rochester
Multi-Cancer Detection Observational Cohort Study
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Mayo Clinic in Rochester, Rochester
Suprachoroidal Administration in Subjects With Metastases to the Choroid
In reclutamentoFase 2
- Mayo Clinic, Rochester
Primary Tumor Research and Outcomes Network
In reclutamentoStudio osservazionale
- Mayo Clinic, Rochester
Testicular Tissue Cryopreservation in Children
In reclutamento
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- Mayo Clinic, Rochester
Studi su Cancro (tutti i tipi) in altre città
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Altri studi a Rochester
- Cancro al seno42 studi
- Cancro del polmone non a piccole cellule37 studi
- Cancro metastatico31 studi
- Cancro colorettale29 studi
- Cancro ovarico29 studi
- Mieloma multiplo24 studi
- Cancro alla prostata22 studi
- Insufficienza cardiaca22 studi
- Cancro pancreatico22 studi
- Cancro ai polmoni20 studi
- Cancro dell'endometrio20 studi
- Leucemia linfatica cronica19 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.